Desarrollo de terapias génicas mínimamente invasivas para el tratamiento de la Mucopolisacaridos tipo IIIA, IIIB, IIIC y IIID y tipo II.

Bosch Tubert, Maria Fatima (Principal Investigator)

Department of Biochemistry and Molecular Biology

Description

No disponible

Status	Finished
Effective start/end date	17/12/12 → 31/12/15

Funding

Spanish Ministry of Economy and Competitiveness (MINECO): €611,035.00
European Regional Development Fund (FEDER)

CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
Motas, S., Haurigot, V., Garcia, M., Marcó, S., Ribera, A., Roca, C., Sánchez, X., Sánchez, V., Molas, M., Bertolin, J., Maggioni, L., León, X., Ruberte, J. & Bosch, F., 16 Jun 2016, In: JCI insight. 1, 9, 19 p., e86696.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
62 Link opens in a new tab Citations (Scopus)

2 Downloads (Pure)